Literature DB >> 21357820

ONTARGET still OFF-TARGET?

Hiddo J Lambers Heerspink, Dick de Zeeuw.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21357820     DOI： 10.1161/CIRCULATIONAHA.111.018382

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  Diabetes: ROADMAP: the road to renoprotection?

Authors:  Sara S Roscioni; Hiddo J Lambers Heerspink; Dick de Zeeuw
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

Review 2.  Combination use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in diabetic kidney disease.

Authors:  Robert C Stanton
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

Review 3.  Telmisartan: a review of its use in cardiovascular disease prevention.

Authors:  James E Frampton
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

Review 4.  Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View.

Authors:  Hiddo J Lambers Heerspink; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

Review 5.  What should be the blood pressure target for patients with chronic kidney disease?

Authors:  Susanne B Nicholas; Nosratola D Vaziri; Keith C Norris
Journal:  Curr Opin Cardiol       Date:  2013-07       Impact factor: 2.161

6.  Chapter 8: Future directions and controversies.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.